baCta Raises €7M Seed for AI Bioproduction Platform

Parisian industrial biotech innovator, baCta, has successfully closed a €7 million Seed funding round, signaling robust investor confidence in its AI-driven bioproduction platform. This significant capital injection, led by prominent venture capital firms LocalGlobe and Daphni, with additional participation from OVNI Capital, is set to accelerate the company's ambitious plans to revolutionize sustainable manufacturing processes.

Founded by visionary entrepreneurs Mathieu Nohet and Marie Rouquette, baCta is at the forefront of leveraging artificial intelligence to optimize microbial fermentation, a critical component in the burgeoning bioeconomy. The company's initial strategic focus is on the high-value production of astaxanthin, a powerful antioxidant with a rapidly expanding market across nutraceuticals, aquaculture, and cosmetics. The global astaxanthin market alone is projected to exceed $1 billion by 2027, driven by increasing consumer demand for natural and sustainable ingredients, making baCta's entry particularly timely.

The infusion of capital will primarily be directed towards scaling baCta's proprietary AI models and expanding its laboratory and pilot production capabilities. This investment underscores a broader trend within the venture capital landscape, where deep tech startups combining biotechnology with advanced computational methods are attracting substantial interest. Investors are increasingly recognizing the potential for AI to unlock efficiencies and discover novel pathways in biomanufacturing, a sector critical for addressing global challenges from sustainable food production to advanced materials.

The involvement of LocalGlobe, known for its early-stage investments in disruptive European tech companies, and Daphni, a fund with a strong track record in supporting innovative French startups, provides baCta with not only financial backing but also strategic guidance and access to extensive networks. OVNI Capital's participation further diversifies the investor base, bringing additional expertise to the table.

This funding round positions baCta to become a key player in the industrial biotechnology sector, which is experiencing exponential growth. The global industrial biotechnology market, valued at approximately $60 billion in 2023, is expected to grow at a compound annual growth rate (CAGR) of over 9% in the coming years. Companies like baCta, by enhancing the efficiency and sustainability of bioproduction, are crucial for this expansion, offering greener alternatives to traditional chemical synthesis and reducing reliance on fossil fuels.

The successful close of this Seed round highlights the increasing maturity and attractiveness of the French biotech ecosystem. With a strong scientific foundation and growing investor appetite, France is solidifying its position as a hub for innovation in life sciences and deep tech. baCta's progress will be closely watched as it aims to bring its AI-powered bioproduction solutions to market, potentially setting new benchmarks for efficiency and sustainability in the production of high-value biochemicals.